Syon Capital’s Bristol-Myers Squibb BMY Stock Holding History

Syon Capital’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$956K	Buy	16,588 +2,193	+15%	+$126K	0.04%	370
2026 Q1	$873K	Buy	14,395 +1,085	+8%	+$63.3K	0.04%	342
2025 Q4	$718K	Buy	13,310 +2,072	+18%	+$99.7K	0.04%	418
2025 Q3	$507K	Sell	11,238 -1,164	-9%	-$54.4K	0.03%	493
2025 Q2	$574K	Sell	12,402 -4,622	-27%	-$227K	0.04%	329
2025 Q1	$1.04M	Buy	17,024 +1,042	+7%	+$60.7K	0.08%	175
2024 Q4	$904K	Buy	15,982 +4,335	+37%	+$242K	0.08%	176
2024 Q3	$603K	Buy	11,647 +1,407	+14%	+$66K	0.05%	241
2024 Q2	$425K	Sell	10,240 -12,461	-55%	-$558K	0.04%	286
2024 Q1	$1.23M	Buy	22,701 +9,276	+69%	+$473K	0.12%	127
2023 Q4	$689K	Buy	13,425 +6,573	+96%	+$345K	0.07%	191
2023 Q3	$398K	Buy	+6,852	New	+$420K	0.05%	220

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Syon Capital's BMY Position: Q2 2026 in Review

Syon Capital increased its Bristol-Myers Squibb (BMY) stake by 15% in Q2 2026, buying an estimated $126K and bringing the position to 16,588 shares worth $956K. The position accounts for 0.04% of the portfolio, ranked #370.

Syon Capital first reported a position in BMY in Q3 2023 and has held it in 12 quarters since. The position peaked at $1.23M in Q1 2024. 2,524 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Syon Capital held 16,588 shares of Bristol-Myers Squibb worth $956K as of Q2 2026.
Syon Capital bought 2,193 Bristol-Myers Squibb shares in Q2 2026, an estimated $126K.
Bristol-Myers Squibb made up 0.04% of Syon Capital's portfolio in Q2 2026, its #370 holding.
Syon Capital first reported a position in Bristol-Myers Squibb in Q3 2023 and has held it in 12 quarters since.
Syon Capital's Bristol-Myers Squibb position peaked at $1.23M in Q1 2024.
2,524 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Syon Capital's 13F filing for Q2 2026, filed 14 Aug 2026.